Apart mentioned above, YB1 expression level was still confirmed to relate to occurrence, development and prognosis of breast cancer, colon cancer, renal cell carcinoma and cervical cancer8,25–28, as well as drug resistance to chemotherapy11,29–31. This evidence concerns the gene YBX1 and renal cell carcinoma.